What You Should Know:
- In a decisive move towards faster and more efficient drug development, QuantHealth, a leading AI-powered clinical trial design company, has secured a strategic investment of $17M.
- The new capital, fueled by Accenture Ventures alongside a prominent CRO and additional investors, bolsters QuantHealth's total Series A funding and propels its mission to revolutionize clinical trials through AI simulations.
Saving Millions with 86% Predictive
Read More
GE HealthCare Acquires MIM Software to Enhance Precision Care
What You Should Know:
- In a move poised to reshape the landscape of precision care, GE HealthCare (Nasdaq: GEHC) has announced the acquisition of MIM Software, a provider of medical imaging analysis and AI solutions.
- This strategic acquisition strengthens GE HealthCare's commitment to developing smart, interconnected devices and digital solutions that empower clinicians to deliver more precise, personalized care across various specialties.
Fueling Innovation in Precision
Read More
Deloitte Unveils Atlas AI: Accelerating Drug Discovery with Generative AI and NVIDIA Power
What You Should Know:
- Deloitte, a global leader in professional services, has unveiled Atlas AI, a groundbreaking addition to its Quartz AI™ suite, marking a significant leap forward in life sciences and healthcare (LSHC).
- Built on the NVIDIA AI and NVIDIA Omniverse™ platforms, Atlas AI empowers scientists with novel tools to expedite drug discovery and bring life-saving treatments to market faster.
Harnessing the Power of Generative AI
Atlas AI boasts a unique arsenal of AI
Read More
Imbed Raises $10M for FDA-Cleared Wound Care Technology
What You Should Know:
Niterra, a global leader in diverse industries, today announced its participation in a $10M convertible debt financing round for Imbed Biosciences, Inc. (Imbed), a rising star in the field of tissue engineering.
- This strategic investment marks Niterra's commitment to supporting innovative solutions that improve patient quality of life and aligns perfectly with its transformation towards non-internal combustion engine businesses.
Revolutionizing Wound Care with
Read More
Goldman Sachs Bets Big on Life Sciences with $650M Fund
What You Should Know:
- Goldman Sachs Asset Management has announced the closing of its first-ever life sciences fund, West Street Life Sciences I, surpassing its target with $650 million in commitments.
- This marks a significant investment in the burgeoning life sciences sector, showcasing Goldman Sachs' confidence in the field's potential to revolutionize healthcare.
West Street Life Sciences Investment Thesis
The fund will focus on growth-oriented private equity investments in
Read More
Nabla’s AI Assistant Gets $24M Boost to Combat Clinician Burnout and Streamline Care
What You Should Know:
- Nabla, a Boston, MA-based ambient AI assistant for healthcare professionals, announced today the initial close of a $24M Series B funding round led by Cathay Innovation, with participation from ZEBOX Ventures.
- The latest round of funding brings Nabla's total funding to over $43M and fuels its mission to revolutionize healthcare delivery by empowering clinicians and improving patient care.
Easing the Burden of EHRs:
Clinicians often cite managing the
Read More
Healthy.io Appoints Geoff Martin as CEO to Drive Commercial Expansion and Global Impact
What You Should Know:
- Healthy.io, the pioneer of smartphone-powered at-home kidney testing, announced Geoff Martin, a seasoned healthcare executive, will take the reins as CEO, while founder Yonatan Adiri transitions to the role of President.
- This move marks a pivotal moment for the company as it enters a new phase of growth, aiming to expand its reach and impact on global healthcare.
Martin's Proven Track Record for Growth
Geoff Martin brings extensive experience in
Read More
MultiPlan Taps Healthcare Tech Veteran Travis Dalton as New CEO to Fuel Growth
What You Should Know:
- MultiPlan Corporation (NYSE: MPLN), a provider of data analytics and technology-enabled healthcare cost management solutions, announced today that Travis Dalton will become its new President and CEO on March 1, 2024.
- He succeeds Dale White, who will transition to the role of Executive Chair, while current Chair Mark Tabak will remain on the Board of Directors.
Dalton's Proven Track Record in Healthcare Technology
Bringing over 20 years of experience in
Read More
Arbital Health Acquires Actuarial Firm & Secures $10M for Value-Based Care Adjudication
What You Should Know:
- Arbital Health, a rising star in the value-based care space, announced a significant double play today, acquiring leading actuarial firm Santa Barbara Actuaries and securing $10 million in Series A funding led by Transformation Capital.
- This strategic move positions Arbital Health as a major player in accelerating the healthcare industry's transition to a more outcome-driven model.
Building the Infrastructure for Value-Based Care
Founded in November 2023 by
Read More
Glytec Appoints Patrick F. Cua as CEO to Drive Growth in Hospital Glycemic Management
What You Should Know:
- Glytec, a provider of cloud-based insulin management software solutions, announced today the appointment of Patrick F. Cua as Chief Executive Officer.
- Cua's extensive experience and deep understanding of the healthcare industry will be crucial as Glytec gears up for rapid growth in the face of rising demand for its Glucommander® software.
Cua Bio/Background
With over three decades of leadership experience in healthcare, Cua brings a wealth of knowledge and
Read More
